Novo Japan Chalks Up Record Sales in 2016 on Tresiba, Victoza

Novo Nordisk Pharma President Ole Moelskov Bech Danish diabetes powerhouse Novo Nordisk A/S notched up record Japan sales of 90.8 billion yen in 2016, up 2.1% year on year, driven by its long-acting insulin analog Tresiba (insulin degludec) and Victoza...read more